Page 36 - Read Online

Page 12 of 14 Xu et al. Cancer Drug Resist 2024;7:13 https://dx.doi.org/10.20517/cdr.2023.141

negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int 2020;20:454. DOI PubMed PMC
42. He ZY, Zhuo RG, Yang SP, et al. CircNCOR1 regulates breast cancer radiotherapy efficacy by regulating CDK2 via hsa-miR-638
binding. Cell Signal 2023;109:110787. DOI PubMed
43. Wang F, Lu Q, Yu H, Zhang XM. The circular RNA circFGFR4 facilitates resistance to anti-PD-1 of triple-negative breast cancer by
targeting the miR-185-5p/CXCR4 axis. Cancer Manag Res 2023;15:825-35. DOI PubMed PMC
44. Wang Z, Li Y, Yang J, et al. Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis. Cell Death Dis
2022;13:776. DOI PubMed PMC
45. He Q, Hao Q, Wu Y, Vadgama JV, Jiang Y. CircRAD54L2 promotes triple-negative breast cancer progression by regulating the miR-
888 family/PDK1 axis. Life Sci 2023;312:121128. DOI PubMed PMC
46. Shao G, Fan X, Zhang P, Liu X, Huang L, Ji S. Circ_0004676 exacerbates triple-negative breast cancer progression through
regulation of the miR-377-3p/E2F6/PNO1 axis. Cell Biol Toxicol 2023;39:2183-205. DOI PubMed
47. Zan X, Li W, Wang G, et al. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during
triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway. Reprod Biol Endocrinol 2022;20:138. DOI
PubMed PMC
48. Gong G, She J, Fu D, Zhen D, Zhang B. CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy
of triple-negative breast cancer. Am J Cancer Res 2022;12:2539-57. PubMed PMC
49. Cui S, Zhang Y, Xing L, Li R, Piao Y, Liu H. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast
cancer progression via miR-362-3p/DDX5 axis. Environ Toxicol 2022;37:1483-94. DOI PubMed
50. Wang X, Song H, Fang L, Wu T. EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by
regulating WBP2 and PI3K/AKT signaling pathway. Cell Death Discov 2022;8:92. DOI PubMed PMC
51. Wang M, Chen D, Zhang H, Luo C. Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on
triple-negative breast cancer cells in vitro. Inflamm Res 2022;71:409-21. DOI PubMed
52. Wang L, Yang X, Zhou F, Sun X, Li S. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via
microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis. Bioengineered 2022;13:7197-208. DOI
PubMed PMC
53. Maimaiti Y, Zhang N, Zhang Y, Zhou J, Song H, Wang S. CircFAM64A enhances cellular processes in triple-negative breast cancer
by targeting the miR-149-5p/CDT1 axis. Environ Toxicol 2022;37:1081-92. DOI PubMed
54. Li J, Gao X, Zhang Z, et al. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS
and IGF2BP2/Myc axes. Mol Cancer 2021;20:138. DOI PubMed PMC
55. Xing Z, Wang R, Wang X, et al. CircRNA circ-PDCD11 promotes triple-negative breast cancer progression via enhancing aerobic
glycolysis. Cell Death Discov 2021;7:218. DOI PubMed PMC
56. Huang Y, Zheng S, Lin Y, Ke L. Circular RNA circ-ERBB2 elevates the warburg effect and facilitates triple-negative breast cancer
growth by the microRNA 136-5p/pyruvate dehydrogenase kinase 4 axis. Mol Cell Biol 2021;41:e00609-20. DOI PubMed PMC
57. Wang L, Zhou Y, Jiang L, et al. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142,
upregulating WWP1 and activating the PI3K/AKT pathway. Mol Cancer 2021;20:43. DOI PubMed PMC
58. Fan Y, Wang J, Jin W, et al. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-
negative breast cancer. Mol Cancer 2021;20:25. DOI PubMed PMC
59. Yang SJ, Wang DD, Zhong SL, et al. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in
triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis. Cell Death Dis 2021;12:420. DOI PubMed
PMC
60. Wang X, Xue B, Zhang Y, Guo G, Duan X, Dou D. Up-regulated circBACH2 contributes to cell proliferation, invasion, and
migration of triple-negative breast cancer. Cell Death Dis 2021;12:412. DOI PubMed PMC
61. Du C, Zhang J, Zhang L, Zhang Y, Wang Y, Li J. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer
via regulating the miR-152-3p/PFTK1 pathway. J Gene Med 2021;23:e3365. DOI PubMed PMC
62. Li H, Xu W, Xia Z, et al. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/
613-led PI3K/Akt/mTOR signaling. Aging 2021;13:4522-51. DOI PubMed PMC
63. Xing L, Yang R, Wang X, et al. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with
prognosis. Aging 2020;12:10983-1003. DOI PubMed PMC
64. He D, Yang X, Kuang W, Huang G, Liu X, Zhang Y. The novel circular RNA circ-PGAP3 promotes the proliferation and invasion of
triple negative breast cancer by regulating the miR-330-3p/Myc axis. Onco Targets Ther 2020;13:10149-59. DOI PubMed PMC
65. Kong Y, Yang L, Wei W, et al. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression. Epigenomics
2019;11:1163-76. DOI PubMed
66. Wu S, Lu J, Zhu H, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.
Cancer Lett 2024;581:216508. DOI PubMed
67. Chen B, Wei W, Huang X, et al. circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression.
Theranostics 2018;8:4003-15. DOI PubMed PMC
68. Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular
RNAs and their interacting proteins and microRNAs. RNA Biology 2016;13:34-42. DOI PubMed PMC
69. Pamudurti NR, Patop IL, Krishnamoorthy A, et al. circMbl functions in cis and in trans to regulate gene expression and physiology in